BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) Operating Margin (2020 - 2026)

Updated

BioAtla (BCAB) recorded Operating Margin of 3.49% in Q2 2026.

Analysis

BioAtla (BCAB) Operating Margin (2020 - 2026) Analysis & Trends

On a TTM basis, BioAtla's Operating Margin came in at -377.94% as of Jun 30, 2026, up 201.83 percentage points year-over-year; for FY2025, it came in at -2965.25%, down 2293.04 percentage points from FY2024.

  • Annual Operating Margin has a five-year change of +4050.83 percentage points (FY2020 to FY2025).
  • Across earlier years, Operating Margin came in at -672.21% in FY2024 and -38576.00% in FY2021 (-31559.92 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,172.45 Bn 1,141.04 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 637.59 Bn 556.11 Bn 17.26 Bn 28.21%
3 AbbVie 504.05 Bn 477.16 Bn 12.70 Bn 37.86%
4 Merck 377.18 Bn 331.56 Bn 12.21 Bn -3.52%
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn 20.57%
7 Amgen 241.83 Bn 197.23 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn -133.21%
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn 28.37%
10 BioAtla 2.24 Mn -16.70 Mn - 3.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.49%
Dec 31, 2025 -462.75%
Sep 30, 2024 -102.45%
Jun 30, 2024 -2,441.33%
Jun 30, 2021 -12,184.00%
Sep 30, 2020 -5,343.33%
Jun 30, 2020 -2,378.95%
Mar 31, 2020 -1,246.07%
API Access

BioAtla Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY